GEERT-JAN MULDER

Profile

First Name

: GEERT-JAN

Middle Name

:

Last Name

: MULDER

Related Companies
Titles
Company Name
Related People
DIRECTOR
TRANSAVE INC
ALEX BARKAS, MARK G. CIPRIANO, RENU GUPTA, NICHOLAS GURRERI, DONALD HAYDEN, JR., RICHARD S. KOLLENDER, STEPHEN H.C. KRAUS, WALTER PERKINS, MICHIO SOGA, ROBERT WEISSKOFF, TIMOTHY WHITTEN
DIRECTOR
GENETIX PHARMACEUTICALS INC
JOHN AGWUNOBI, CHIP BAIRD, JASON COLE, WENDY DIXON, JAMES A. GERAGHTY, STEVEN GILLIS, RAMY IBRAHIM, NICK LESCHLY, DANIEL S. LYNCH, JOHN M. MARAGANORE, AXEL POLACK, WILLIAM R. SELLERS, ROBERT TEPPER, DENICE TORRES, MARK VACHON, JEFFREY T. WALSH
DIRECTOR
PROMEDIOR INC
JAMES W BRODERICK, JAMES W. BRODERICK, JAMES W. BRODERICK, M.D., DOMINICK C COLANGELO, DOMINICK C. COLANGELO, JOHN FRIEDMAN, JOHN H. FRIEDMAN, PAUL D GOLDENHEIM, PAUL D. GOLDENHEIM, PAUL D. GOLDENHEIM, M.D., LARRY KAUVAR, MARK LUPHER, AMIR NASHAT, HANNS A. PIELENZ, HAROLD R WERNER, HAROLD R. WERNER, JOSEPH ZAKRZEWSKI, JOSEPH S. ZAKRZEWSKI
DIRECTOR
EXOSOME THERANOSTICS, INC.
SARA BARRINGTON, JOHN BOYCE, JOSEPH BOYSTAK, WAYNE COMPER, KAPIL DHINGRA, PETER JOHANN, DHINGRA KAPIL, WILLIAM KELLY, JAMES MCCULLOUGH, THOMAS MCLAIN, GEORG NEBGEN, DAVID OKRONGLY, JOSEPH SLATTERY, STEVEN SOIGNET, GREG ZDECHLIK
DIRECTOR
BLUEBIRD BIO, INC.
JOHN AGWUNOBI, CHIP BAIRD, JASON COLE, WENDY DIXON, JAMES A. GERAGHTY, STEVEN GILLIS, RAMY IBRAHIM, NICK LESCHLY, DANIEL S. LYNCH, JOHN M. MARAGANORE, AXEL POLACK, WILLIAM R. SELLERS, ROBERT TEPPER, DENICE TORRES, MARK VACHON, JEFFREY T. WALSH
DIRECTOR
EXOSOME DIAGNOSTICS, INC.
SARA BARRINGTON, JOHN BOYCE, JOSEPH BOYSTAK, WAYNE COMPER, KAPIL DHINGRA, PETER JOHANN, DHINGRA KAPIL, WILLIAM KELLY, JAMES MCCULLOUGH, THOMAS MCLAIN, GEORG NEBGEN, DAVID OKRONGLY, JOSEPH SLATTERY, STEVEN SOIGNET, GREG ZDECHLIK
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-07-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-21 
2015-09-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-31 
2015-07-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-19 
2014-03-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-03 
2013-08-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-10 
2013-06-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-10 
2013-02-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-10 
2012-08-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-10 
2012-07-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-23 
2012-03-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-21 
2011-10-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-10-04 
2011-04-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-05 
2011-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2010-09-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-17 
2010-06-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-06-16 
2010-05-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-28 
2010-03-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-05 
2010-03-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-01 
2009-11-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-10-26